Table 1

Baseline characteristics of patients admitted with severe IPF exacerbations

All (n=5256)
Age—years ±SD73.6 ±9.3
Male, n (%)3267 (62)
Race, n (%)
 White4328 (82)
 Black335 (6.4)
 Asian147 (2.8)
 Other330 (6.3)
 Unknown116 (2.2)
Hispanic, n (%)426 (8.1)
Admission source, n (%)
 Home4559 (87)
 Clinic501 (9.5)
 Other196 (3.7)
Insurance status, n (%)
 Medicaid/uninsured285 (5.4)
 Medicare4204 (80)
 Private635 (12.1)
Acute organ dysfunction, n (%)*
 Cardiovascular443 (8.4)
 Respiratory951 (18.1)
 Neurologic260 (4.9)
 Haematologic302 (5.7)
 Hepatic14 (0.3)
 Renal788 (15)
Comorbidities, n (%)*
 Alcohol abuse84 (1.6)
 Any tumour360 (6.8)
 Cardiac arrhythmias1788 (34)
 Chronic pulmonary disease3531 (67)
 Coagulopathy362 (6.9)
 Complicated diabetes1047 (20)
 Congestive heart failure2142 (41)
 Deficiency anaemia830 (16)
 Dementia281 (5.3)
 Fluid and electrolyte disorder1891 (36)
 HIV/AIDS9 (0.2)
 Hemiplegia15 (0.3)
 Hypertension3768 (72)
 Liver disease199 (3.8)
 Metastatic cancer119 (2.3)
 Peripheral vascular disease452 (8.6)
 Psychosis853 (16)
 Pulmonary circulation disorder1972 (35)
 Renal failure1093 (21)
 Weight loss729 (14)
Mechanically ventilated within first 24 hours of admission, n (%)457 (8.4)
Prior IPF hospitalisation, n (%)154 (2.9)
  • *Acute organ dysfunction and comorbidities identified by ICD-10 codes present on admission (online supplemental appendix 1).

  • IPF, idiopathic pulmonary fibrosis.